Fiona C. Brown

2.1k total citations
27 papers, 697 citations indexed

About

Fiona C. Brown is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Fiona C. Brown has authored 27 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Hematology and 9 papers in Genetics. Recurrent topics in Fiona C. Brown's work include Acute Myeloid Leukemia Research (9 papers), Erythrocyte Function and Pathophysiology (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Fiona C. Brown is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Erythrocyte Function and Pathophysiology (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Fiona C. Brown collaborates with scholars based in Australia, United States and France. Fiona C. Brown's co-authors include Alex Kentsis, Elisa de Stanchina, Casie Reed, Marian C. Okondo, Sahana D. Rao, Darren C. Johnson, Elizabeth Peguero, Ashley J. Chui, Cornelius Y. Taabazuing and Daniel A. Bachovchin and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Fiona C. Brown

25 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona C. Brown Australia 13 470 260 146 143 99 27 697
Aaron C. Trotman-Grant Canada 6 386 0.8× 250 1.0× 161 1.1× 106 0.7× 45 0.5× 12 583
Anand Jillella United States 12 456 1.0× 379 1.5× 136 0.9× 166 1.2× 113 1.1× 48 841
Jonas Ungerbäck Sweden 18 534 1.1× 135 0.5× 426 2.9× 209 1.5× 59 0.6× 30 978
Parvathi Ranganathan United States 14 538 1.1× 230 0.9× 156 1.1× 107 0.7× 69 0.7× 37 764
Jörn Lausen Germany 18 670 1.4× 180 0.7× 96 0.7× 141 1.0× 62 0.6× 33 928
Wenyi Shen China 13 367 0.8× 105 0.4× 144 1.0× 91 0.6× 83 0.8× 55 597
W-D Ludwig Germany 13 397 0.8× 278 1.1× 148 1.0× 190 1.3× 149 1.5× 13 756
Subrata Banerjee India 13 269 0.6× 92 0.4× 121 0.8× 159 1.1× 38 0.4× 31 538
Farshid Radparvar United States 8 473 1.0× 199 0.8× 169 1.2× 141 1.0× 86 0.9× 15 737
Jianping Jin United States 8 517 1.1× 49 0.2× 96 0.7× 51 0.4× 29 0.3× 9 703

Countries citing papers authored by Fiona C. Brown

Since Specialization
Citations

This map shows the geographic impact of Fiona C. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona C. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona C. Brown more than expected).

Fields of papers citing papers by Fiona C. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona C. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona C. Brown. The network helps show where Fiona C. Brown may publish in the future.

Co-authorship network of co-authors of Fiona C. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona C. Brown. A scholar is included among the top collaborators of Fiona C. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona C. Brown. Fiona C. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takao, Sumiko, Shuyuan Cheng, Fiona C. Brown, et al.. (2025). Epigenetic mechanisms controlling human leukemia stem cells and therapy resistance. Nature Communications. 16(1). 3196–3196. 5 indexed citations
2.
Brown, Fiona C., Richard W. Birkinshaw, Chong Chyn Chua, et al.. (2024). Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia. Blood Advances. 9(1). 127–131. 7 indexed citations
3.
Brown, Fiona C. & Catherine Carmichael. (2024). Patient-Derived Xenograft Models for Leukemias. Methods in molecular biology. 2806. 31–40.
4.
Diepstraten, Sarah T., Yuan Yin, Catherine Chang, et al.. (2024). Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers. Cancer Cell. 42(5). 850–868.e9. 25 indexed citations
5.
Yin, Yuan, Sarah T. Diepstraten, Fiona C. Brown, et al.. (2023). Direct, Potent, and TP53-Independent Activity of Sting Agonists Against Acute Myeloid Leukaemia Enhances Venetoclax Efficacy In Vivo. Blood. 142(Supplement 1). 4163–4163. 1 indexed citations
6.
So, Joan, Alexander C. Lewis, Lorey Smith, et al.. (2022). Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia. EMBO Molecular Medicine. 14(7). e15203–e15203. 17 indexed citations
7.
Chua, Chong Chyn, Andrew W. Roberts, John Reynolds, et al.. (2020). Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy. Journal of Clinical Oncology. 38(30). 3506–3517. 117 indexed citations
8.
Hortle, Elinor, Lora Starrs, Fiona C. Brown, et al.. (2019). KCC1 Activation protects Mice from the Development of Experimental Cerebral Malaria. Scientific Reports. 9(1). 6356–6356. 2 indexed citations
9.
Johnson, Darren C., Cornelius Y. Taabazuing, Marian C. Okondo, et al.. (2018). DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nature Medicine. 24(8). 1151–1156. 268 indexed citations
10.
Ramaswamy, Kavitha, Lauren Forbes, Gerard Minuesa, et al.. (2018). Peptidomimetic blockade of MYB in acute myeloid leukemia. Nature Communications. 9(1). 110–110. 68 indexed citations
11.
Brown, Fiona C., Elinor Hortle, Gaétan Burgio, et al.. (2018). Bone marrow transplantation corrects haemolytic anaemia in novel ENU mutagenesis mouse model of TPI deficiency. Disease Models & Mechanisms. 11(5). 12 indexed citations
12.
Brown, Fiona C., et al.. (2017). A mouse model of hereditary coproporphyria identified in an ENU mutagenesis screen. Disease Models & Mechanisms. 10(8). 1005–1013. 6 indexed citations
13.
Brown, Fiona C., Michael Collett, Cédric S. Tremblay, et al.. (2017). Loss of Dynamin 2 GTPase function results in microcytic anaemia. British Journal of Haematology. 178(4). 616–628. 7 indexed citations
14.
Brown, Fiona C., Paolo Cifani, Esther Drill, et al.. (2016). Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia. British Journal of Haematology. 176(1). 86–91. 21 indexed citations
15.
Tremblay, Cédric S., Fiona C. Brown, Michael Collett, et al.. (2016). Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling. Leukemia. 30(10). 1993–2001. 45 indexed citations
16.
Brown, Fiona C., Loretta Cerruti, Janelle E. Collinge, et al.. (2015). Activation of the erythroid K-Cl cotransporter Kcc1 enhances sickle cell disease pathology in a humanized mouse model. Blood. 126(26). 2863–2870. 16 indexed citations
17.
He, Yinghong, Gerhard Rank, Miaomiao Zhang, et al.. (2013). Induction of human fetal hemoglobin expression by adenosine-2’,3’-dialdehyde. Journal of Translational Medicine. 11(1). 14–14. 15 indexed citations
18.
19.
Brown, Fiona C., Nicholas A. Scott, Gerhard Rank, et al.. (2012). ENU mutagenesis identifies the first mouse mutants reproducing human β-thalassemia at the genomic level. Blood Cells Molecules and Diseases. 50(2). 86–92. 15 indexed citations
20.
Brown, Fiona C., Michael Collett, Phillip J. Robinson, et al.. (2012). A Novel DNM2 Mutation Displaying Embryonic Lethality and Impaired Transferrin Uptake Identified in a Mouse ENU Mutagenesis Screen for Genes Perturbing Erythropoiesis. Blood. 120(21). 608–608. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron C. Trotman-Grant Breakdown of academic impact, for papers by Anand Jillella Breakdown of academic impact, for papers by Jonas Ungerbäck Breakdown of academic impact, for papers by Parvathi Ranganathan Breakdown of academic impact, for papers by Jörn Lausen Breakdown of academic impact, for papers by Wenyi Shen Breakdown of academic impact, for papers by W-D Ludwig Breakdown of academic impact, for papers by Subrata Banerjee Breakdown of academic impact, for papers by Farshid Radparvar Breakdown of academic impact, for papers by Jianping Jin
Rankless by CCL
2026